-
1
-
2
Racial and Ethnic Disparities in Cardiotoxicity in Patients With Cancer Treated With Anthracyclines
Published 2025-04-01Subjects: “…anthracycline…”
Get full text
Article -
3
Acute myeloid leukemia presenting with hepatic dysfunction: Should induction be dose reduced?
Published 2024-10-01Subjects: “…anthracycline…”
Get full text
Article -
4
MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances
Published 2025-08-01Subjects: “…anthracycline…”
Get full text
Article -
5
Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy
Published 2011-01-01Subjects: “…Anthracycline…”
Get full text
Article -
6
Randomized, Placebo‐Controlled, Triple‐Blind Clinical Trial of Ivabradine for the Prevention of Cardiac Dysfunction During Anthracycline‐Based Cancer Therapy
Published 2025-05-01Subjects: “…anthracycline…”
Get full text
Article -
7
Effects of taxane-anthracycline and taxane only treatment on cardiac function in breast cancer—a retrospective cohort study
Published 2025-04-01Subjects: Get full text
Article -
8
-
9
The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (rev...
Published 2024-09-01Subjects: “…anthracycline chemotherapy drug…”
Get full text
Article -
10
Can Dexrazoxane and Carvedilol prevent Doxorubicin-induced nephrotoxicity?
Published 2024-12-01Subjects: “…post-anthracycline nephrotoxicity…”
Get full text
Article -
11
Extravascular leakage of dexrazoxane that occurred in a patient with diffuse large B-cell lymphoma: a case report
Published 2025-06-01Subjects: Get full text
Article -
12
The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review)
Published 2024-03-01Subjects: “…anthracycline chemotherapy drug…”
Get full text
Article -
13
Efficacy and harms associated with β-blockers for cardiotoxicity in cancer patients undergoing chemotherapy: a systematic review and meta-analysis
Published 2024-06-01Subjects: Get full text
Article -
14
Complexation reaction with Sm(III): a facile spectrophotometric quantification of daunorubicin in pharmaceutical preparation and biological fluids
Published 2025-08-01Subjects: Get full text
Article -
15
Clinical, Echocardiographic and Laboratory Cardiac Monitoring in Breast Cancer Patients Undergoing Chemotherapy with Anthracycline Agents: A Pilot Study on Cardioprotective Algorit...
Published 2025-07-01Subjects: “…anthracycline, cardiac dysfunction, global longitudinal strain, ferritin…”
Get full text
Article -
16
Clinical Significance of Expression of Topoisomerase 2а in Breast Cancer
Published 2020-05-01Subjects: Get full text
Article -
17
Cardio- and nephroprotective effects of fractions isolated from Lycium barbarum (goji berry) in models of cardio- and nephrotoxicity in rats
Published 2023-03-01Subjects: Get full text
Article -
18
Evaluation of left atrial strain changes in patients with breast cancer after anthracycline therapy
Published 2025-05-01Subjects: Get full text
Article -
19
RISK FACTORS AND INCIDENCE OF MYOCARDIAL DAMAGE IN PATIENTS WITH HEMOBLASTOSIS RECEIVING ANTHRACYCLIN ANTIBIOTICS
Published 2017-10-01Subjects: Get full text
Article -
20